HealthEquity, Inc. (Nasdaq: HQY) delivered impressive results in the first quarter of fiscal 2024, with an EPS of $0.50, surpassing the consensus estimate of $0.41. 

Buoyed by this strong performance, the company has raised its outlook for the full fiscal year 2024. HealthEquity now expects non-GAAP net income per diluted share to be in the range of $1.88 to $1.97, compared to the consensus estimate of $1.77 for the period. 

After-hours trading saw $HQY at $62.49, experiencing a notable increase of $3.65 (+6.20%).

Sprinklr, Inc. (NYSE: CXM) also delivered solid results in the first quarter of fiscal 2024, reporting an adjusted EPS of $0.06, surpassing the consensus estimate of $0.01.

Looking ahead to the full fiscal year 2024, Sprinklr expects non-GAAP net income per share to be between $0.19 and $0.21, compared to the consensus estimate of $0.14 for the period. 

$CXM was trading at $14.10 in after-hours, up $0.61 (+4.52%).

Piedmont Lithium Inc. (Nasdaq: PLL), a lithium mining and exploration company, received a price target raise from $90 to $96 by DA Davidson.

Despite closing at $61.43 on Monday, this upward adjustment in the price target indicates a potential upside of $34.57 (+56.34%) for $PLL, based on DA Davidson's analysis. 

Murphy Oil Corporation (NYSE: MUR), an oil and gas exploration and production company, had its price target raised from $56 to $60 by Truist Securities.

Considering that $MUR closed at $36.71 on Monday, this revised price target suggests a potential upside of $23.29 (+63.38%) according to Truist Securities' view.

It is important to consider that the potential upsides mentioned above are based on the assessments provided by different brokerage firms, investment firms, or analysts. These estimates should be utilized in conjunction with the prevailing market dynamics and aligned with individual investment strategies. They offer informative viewpoints within the investment landscape, but investors should exercise due diligence and make informed decisions based on their own research and analysis.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)